The last patient, suffering from systemic mastocytosis with eosinophilia, was negative to FIP1L1-PDGFRA rearrangement, as well as to the C-KIT-D816V mutation, but did not respond to imatinib treatment. This evidence concerns the gene PDGFRA and Increased total eosinophil count.